Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2017-18228
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
Remedy Mid Tier in BMC Remedy AR System 9.1 allows XSS via the ATTKey parameter in an arsys/servlet/AttachServlet request.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
BMC Remedy AR System Remedy Mid Tier 跨站请求伪造漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
BMC Remedy AR System是美国BMC Software公司的一套用于IT部门的移动数字化企业管理平台。Remedy Mid Tier是其中的一个中间件。 BMC Remedy AR System 9.1版本中的Remedy Mid Tier存在跨站请求伪造漏洞。远程攻击者可借助arsys/servlet/AttachServlet请求中的‘ATTKey’参数利用该漏洞执行脚本。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
-n/a n/a -
II. Public POCs for CVE-2017-18228
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2017-18228
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2017-18228

No comments yet


Leave a comment